tacrolimus and Arm-Injuries

tacrolimus has been researched along with Arm-Injuries* in 2 studies

Other Studies

2 other study(ies) available for tacrolimus and Arm-Injuries

ArticleYear
[First case in the world of autoreplantation of a limb associated with oral administration of an immunosupressant agent (FK 506-Tacrolimus)].
    Annales de chirurgie plastique et esthetique, 2005, Volume: 50, Issue:4

    This is the case of the replantation of the upper limb of a sixty year old woman. The nature of the traumatism is an avulsion of the upper limb, at the junction of the middle third and the lower third of the humerus, which has a very bad prognosis. The originality of this report is the administration of Tacrolimus (immunosuppressive molecule) in an autotransplant. Tracolimus stimulates the nerve growing back, as already demonstrated in the animal and the fetus. In this preliminary report, the use of Tacrolimus over one year showed exceptional results. Indeed, the autors noticed clinical signs of intrinsic reinervation of the hand in the territory of the ulnar and median nerve. This has been confirmed with the use of electromyography. This is, as far as we know, the first observation of such results with adults and when the level of amputation is located so high. The authors think that the use of Tacrolimus should be tested in numerous cases of nerve lesions with bad prognosis such as high ulnar nerve lesions, serious plexus suffering or even in spinal cord trauma.

    Topics: Administration, Oral; Arm Injuries; Electromyography; Female; Humans; Immunosuppressive Agents; Middle Aged; Prognosis; Replantation; Tacrolimus; Transplantation, Autologous; Treatment Outcome; Ulnar Nerve

2005
Clinical outcome following nerve allograft transplantation.
    Plastic and reconstructive surgery, 2001, Volume: 107, Issue:6

    The clinical outcome of seven patients who underwent reconstruction of long upper- and lower-extremity peripheral nerve gaps with interposition peripheral nerve allografts is reported. Patients were selected for transplantation when the nerve gaps exceeded the length that could be reconstructed with available autograft tissue. Before transplantation, cadaveric allografts were harvested and preserved for 7 days in University of Wisconsin Cold Storage Solution at 5 degrees C. In the interim, patients were started on an immunosuppressive regimen consisting of either cyclosporin A or tacrolimus (FK506), azathioprine, and prednisone. Immunosuppression was discontinued 6 months after regeneration across the allograft(s) was evident. Six patients demonstrated return of motor function and sensation in the affected limb, and one patient experienced rejection of the allograft secondary to subtherapeutic immunosuppression. In addition to providing the ability to restore nerve continuity in severe extremity injuries, successful nerve allografting protocols have direct applicability to composite tissue transplantation.

    Topics: Adolescent; Adult; Arm Injuries; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Leg Injuries; Male; Peripheral Nerve Injuries; Peripheral Nerves; Plastic Surgery Procedures; Soft Tissue Injuries; Tacrolimus; Treatment Outcome

2001